Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > 1次抗体

Anti-AIFM2/FSP1 Polyclonal Antibody (HC098014)

価格(USD):
スペック:
  • 50ug
  • 100ug
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HC098014
説明
Anti-AIFM2/FSP1 Polyclonal Antibody (HC098014) is a rabbit polyclonal antibody detecting AIFM2 in ELISA, IHC, WB. Suitable for Human, Mouse, and Bovine.
Highlights
  • ●Affinity Purified — Minimal background and high purity for reliable results.
  • ●Multi-Application — Validated across multiple applications.
  • ●Multi-Species — Cross-reactive for translational research.
種反応性Human
アプリケーションELISA, IHC, WB
宿主種Rabbit
クローン性Polyclonal
アイソタイプIgG
免疫原 E. coli - derived recombinant AIFM2/FSP1 (Met1-Pro373).
ターゲット Ferroptosis suppressor protein 1, FSP1, EC:1.6.5.-, Apoptosis-inducing factor homologous mitochondrion-associated inducer of death, AMID, p53-responsive gene 3 protein, AIFM2, AMID, PRG3
エンドトキシンレベル Please contact with the lab for this information.
精製 Purified by antigen affinity column.
アクセッション番号 Q9BRQ8, Q8BUE4, A5PJM4
形態 Liquid
保存バッファー 0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

製品使用情報
アプリケーション 希釈
ELISA 1:5000-1:20000
IHC 1:50-1:500
WB 1:500-1:2000
安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
背景

Ferroptosis suppressor protein 1 (AIFM2/FSP1) is a ~40 kDa protein. A NAD(P)H-dependent oxidoreductase that acts as a key inhibitor of ferroptosis. At the plasma membrane, catalyzes reduction of coenzyme Q/ubiquinone-10 to ubiquinol-10, a lipophilic radical-trapping antioxidant that prevents lipid oxidative damage and consequently ferroptosis. Acts in parallel to GPX4 to suppress phospholipid peroxidation and ferroptosis. This anti-ferroptotic function is independent of cellular glutathione levels. Also acts as a potent radical-trapping antioxidant by mediating warfarin-resistant vitamin K reduction in the canonical vitamin K cycle: catalyzes NAD(P)H-dependent reduction of vitamin K (phylloquinone, menaquinone-4 and menadione) to hydroquinone forms.

1. Doll, S. et al. (2019) Nature 575, 693-698. PMID: 31634899
2. Bersuker, K. et al. (2019) Nature 575, 688-692. PMID: 31634900
3. Mishima, E. et al. (2022) Nature 608, 778-783. PMID: 35922516
4. Jin, DY. et al. (2023) Nature communications 14, 828. PMID: 36788244
5. Nakamura, T. et al. (2023) Nature structural & molecular biology 30, 1806-1815. PMID: 37957306
6. Li, W. et al. (2025) The EMBO journal 44, 1641-1662. PMID: 39881208
7. Zhang, S. et al. (2023) Cell research 33, 967-970. PMID: 37739993
8. Lan, H. et al. (2024) Cell discovery 10, 88. PMID: 39160155
9. Feng, S. et al. (2024) MedComm 5, e479. PMID: 38414669
10. Yang, JS. et al. (2025) Cell 188, 2569-2585.e20. PMID: 40233740
注意事項 For research use only
イメージ
参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト